UBE3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.843200E-01
Normal-vs-Stage2
2.901200E-01
Normal-vs-Stage3
6.142100E-02
Normal-vs-Stage4
4.349600E-01
Stage1-vs-Stage2
2.694400E-01
Stage1-vs-Stage3
1.169180E-01
Stage1-vs-Stage4
6.285400E-01
Stage2-vs-Stage3
4.971700E-02
Stage2-vs-Stage4
9.190800E-01
Stage3-vs-Stage4
1.155980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.111600E-01
Normal-vs-AfricanAmerican
1.563160E-01
Normal-vs-Asian
1.236960E-01
Caucasian-vs-AfricanAmerican
3.864600E-01
Caucasian-vs-Asian
1.190440E-01
AfricanAmerican-vs-Asian
7.674200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.276000E-01
Normal-vs-Female
3.087600E-01
Male-vs-Female
4.458200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.233400E-01
Normal-vs-Age(41-60Yrs)
4.817000E-01
Normal-vs-Age(61-80Yrs)
2.824200E-01
Normal-vs-Age(81-100Yrs)
6.137200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.051200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.144800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.611400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.172300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.647000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.962200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.371350E-01
Normal-vs-Daily Drinker
5.538800E-01
Normal-vs-Weekly Drinker
5.121200E-01
Normal-vs-Occasional Drinker
9.366000E-01
Normal-vs-Social Drinker
4.527600E-01
Non Drinker-vs-Daily Drinker
9.900300E-02
Non Drinker-vs-Weekly Drinker
3.073200E-01
Non Drinker-vs-Occasional Drinker
4.375000E-03
Non Drinker-vs-Social Drinker
1.507210E-01
Daily Drinker-vs-Weekly Drinker
7.547000E-01
Daily Drinker-vs-Occasional Drinker
2.750200E-01
Daily Drinker-vs-Social Drinker
8.957600E-01
Weekly Drinker-vs-Occasional Drinker
2.178600E-01
Weekly Drinker-vs-Social Drinker
8.460800E-01
Occasional Drinker-vs-Social Drinker
2.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.195800E-01
Normal-vs-Grade 2
5.812800E-01
Normal-vs-Grade 3
5.076000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.562600E-01
Grade 1-vs-Grade 3
5.953800E-01
Grade 1-vs-Grade 4
2.195800E-01
Grade 2-vs-Grade 3
3.123700E-02
Grade 2-vs-Grade 4
5.812800E-01
Grade 3-vs-Grade 4
5.076000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.496400E-01
Normal-vs-NonDiabetic
4.164400E-01
Diabetic-vs-NonDiabetic
2.234200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.686400E-01
Normal-vs-NoPancreatitis
3.722800E-01
Pancreatitis-vs-NoPancreatitis
7.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.769000E-01
Normal-vs-N1
3.042400E-01
N0-vs-N1
8.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.123200E-01
Normal-vs-TP53-NonMutant
6.908000E-01
TP53-Mutant-vs-TP53-NonMutant
8.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
